COELHO PHILIP H 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 8, 2022
Insider Transaction Report
Form 4
COELHO PHILIP H
Director
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2022-12-06+1,334→ 150,887 total - Award
Restricted Stock Units
2022-12-06−1,334→ 295,500 total→ Common Stock (1,334 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022.